A case of lung adenocarcinoma with a novel CD74‐ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib

ROS1 rearrangements are found in 1–2% of patients with non‐small‐cell lung cancer. The detection of the rearrangements is crucial since clinically effective molecular targeted drugs are available for them. We present a case of lung adenocarcinoma with a previously unknown ROS1‐CD74 fusion variant, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashiguchi, Mizuha Haraguchi, Sato, Takashi, Watanabe, Rinako, Kagyo, Junko, Matsuzaki, Tomohiko, Domoto, Hideharu, Kato, Terufumi, Nakahara, Yoshiro, Yokose, Tomoyuki, Hiroshima, Yukihiko, Shiomi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447907/
https://www.ncbi.nlm.nih.gov/pubmed/34319660
http://dx.doi.org/10.1111/1759-7714.14093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447907/
https://www.ncbi.nlm.nih.gov/pubmed/34319660
http://dx.doi.org/10.1111/1759-7714.14093

Ejemplares similares